by 30 Technology | Feb 22, 2021 | News
30 Technology enters into a strategic Licencing Agreement to develop new treatments for multi-drug resistant tuberculosis Thirty Technology joins the fight against antibiotic resistant infection. London, UK, 22 February 2021. Thirty Holdings Limited (“30 Technology”)...
by 30 Technology | Feb 19, 2021 | News
30 Technology launches a critical clinical trial of RESP301 in cystic fibrosis patients with serious lung infections RESP301 to combat antibiotic resistant/refractory infection in people with cystic fibrosis London, UK, 19 February 2021. Thirty Respiratory (“30...
by 30 Technology | Feb 15, 2021 | Careers
LABORATORY ANALYST or DEVELOPMENT ANALYST TECHNICAL OPERATIONS 30 TECHNOLOGY MILTON PARK, ABINGDON This is a fantastic opportunity for a self-motivated individual to train as either a Laboratory Analyst or Development Analyst within the Technical Operations group. You...
by 30 Technology | Feb 15, 2021 | Careers
PUBLIC RELATIONS (PR) ASSISTANT 30 TECHNOLOGY We are looking for a promising Public Relations (PR) Assistant to support our executive team with various administrative tasks. Though you’ll be holding an entry level position, your work will be instrumental in the...
by 30 Technology | Jan 15, 2021 | News
Thirty Respiratory receives approval for multicentre post-exposure clinical trial of RESP301 to prevent transmission of COVID-19 in the community Break-through new treatment to protect people at risk from COVID-19 London, UK, 15 January 2021. Thirty Respiratory (“30...
Recent Comments